Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this event. The technology recreates a human blood vessel and shows how new capillaries grow from a single vessel (parent vessel) in response to proper biochemical signaling cues.
Altertox Academy (former CAAT Academy) and Epithelix are organising a 2-days “LIVe2018 - Lung In Vitro event for innovative & predictive models” congress in 2018.
In cooperation with scientists from Minneapolis, the Netherlands and Málaga, a researcher team from the Stem Cell Institute of the Katholieke Universiteit te Leuven led by Prof. Catherine Verfaillie succeeded in producing oligodendrocytes from human induced pluripotent stem cells by an overexpression of the transcription factor SOX10.
Scientists from the Beth Israel Deaconess Medical Center and the Wyss Institute at Harvard University in Boston have developed a thrombosis model on the basis of a blood-vessel-on-a-chip model to investigate cellular processes involved in treating vascular inflammation with a platelet aggregation inhibitor.
According to the Berliner Morgenpost`s current issue, the financing contracts between the Senate of Berlin and the 11 state universities as well as the Charité were signed yesterday. In this program, the new centre for alternatives to animal testing will be provided with euros 8,5 millions.